Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ: DXCM )

88.75 +1.05 (+1.20%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about DexCom, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Demystifying DexCom: Insights From 15 Analyst Reviews
Via Benzinga
ON Semiconductor Posts Upbeat Earnings, Joins Oil States International, CommScope Holding And Other Big Stocks Moving Higher On Monday
Via Benzinga
Behind the Scenes of DexCom's Latest Options Trends
Via Benzinga
Despite its growth, NASDAQ:DXCM remains within the realm of affordability.
In the world of growth stocks, NASDAQ:DXCM shines as a value proposition. 
Via Chartmill
Is Beaten-Down Dexcom Stock a Buy on the Dip?
The market may have overreacted to a disappointing earnings report. 
Via The Motley Fool
Why DexCom Stock Is Crashing Today
Investors are worried about the diabetes care technology leader's slowing growth. 
Via The Motley Fool
2 Unstoppable Growth Stocks to Buy Right Now for Less Than $1,000
These profitable businesses have a lot to offer the long-term investor. 
Via The Motley Fool
2 Magnificent Growth Stocks to Buy Right Now
These top stocks are looking increasingly attractive for a long-term investment. 
Via The Motley Fool
S&P 500 Gains Over 1%; 3M Shares Jump After Q2 Results
Via Benzinga
Topics Stocks
Exposures US Equities
Dow Recovers Weekly Losses With 600-Point Pop
The Dow Jones Industrial Average is soaring today, up 608 points at last look and breaking into positive territory for the week. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Crude Oil Down Over 2%; Bristol Myers Squibb Posts Upbeat Q2 Results
Via Benzinga
Exposures Fossil Fuels
Wall Street Enjoys Late-Week Rally On Benign Inflation Data, Dow Jones Eyes Best Session Of 2024, Tech Unwinding Stalls: What's Driving Markets Friday?
After a turbulent week in the markets, the bulls reclaimed dominance on Wall Street during Friday’s session, with indices and sectors trading in positive territory as investors welcomed the latest... 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
DexCom Faces Short-Term Challenges, But Market Growth Prospects Remain Strong: Analyst
DexCom reports Q2 sales of $1.004B, up 15% YoY, with adjusted EPS of $0.43, beating the $0.39 consensus. Despite lowering 2024 sales guidance to $4.00-$4.05B, William Blair maintains an Outperform... 
Via Benzinga
Why DexCom Stock Is Trading Lower Friday
DexCom shares are trading lower Friday after the company reported worse-than-expected second quarter revenue and issued weak guidance. 
Via Benzinga
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Kroger and Albertsons Pause Merger Deal: KR and ACI Stocks on Watch
Kroger and Albertsons are gearing up for a Colorado lawsuit that has put the combination of the two grocery companies on hold. 
Via InvestorPlace
Topics Lawsuit
Exposures Financial Legal
Stock Market Diverges, With Tesla, Google, ServiceNow, GE In Focus: Weekly Review
Small caps continued to lead, while the Nasdaq broke below key levels. 
Via Investor's Business Daily
Dexcom (DXCM) Stock Is Plunging on an ‘Execution Miss.’ What Is Really Going On?
Dexcom's Stelo faces an uncertain future thanks to drugs like Wegovy and a competing Abbott Labs product. DXCM stock is down 40% today. 
Via InvestorPlace
LTM Stock IPO: 7 Things to Know as LATAM Airlines Returns to the NYSE
LATAM Airlines stock is back on the NYSE alongside an IPO for LTM shares after they were delisted from the market back in 2020. 
Via InvestorPlace
Topics Initial Public Offering
Exposures Securities Market
Why Is Zynex (ZYXI) Stock Down 24% Today?
Zynex stock is falling on Friday as ZYXI investor react to earnings misses and poor guidance for Q3 and the full year of 2024. 
Via InvestorPlace
Topics Earnings
Exposures Financial
Why Is DexCom (DXCM) Stock Down 38% Today?
DexCom stock is up on Friday as DXCM investors react to the company's latest earnings report and its lackluster 2024 guidance. 
Via InvestorPlace
DexCom, Zynex, Olin And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
This Southwest Airlines Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Via Benzinga
Dexcom Shares Plummet Nearly 39% In Pre-Market After Lowering Full-Year Sales Outlook
During an analyst call, Dexcom executives attributed the forecast cut to fewer new customers and lower revenue per customer than expected. 
Via Benzinga
US Stocks Look To End Week On High Note As Nvidia Leads Mega-Caps Higher In Premarket Ahead Of Key Inflation Data
After the severe pounding the tech space received in the past three sessions, it might be rebound time. However, any recovery will largely hinge on whether key inflation data confirms the continued... 
Via Benzinga
Topics Economy
Exposures Interest Rates
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Pre-market stock movers are worth diving into this morning as we check out all of the hottest news investors need to know about on Friday! 
Via InvestorPlace
Why Is Omnipod Insulin Device Maker Insulet Stock Jumping Today?
Insulet Corporation shares are rising after the company reported stronger-than-expected second-quarter revenue, driven by high demand for Omnipod 5 and a raised full-year revenue outlook. 
Via Benzinga
Get Your Money Out of These 3 Nasdaq Stocks by the End of July
Discover why these three Nasdaq stocks may be worth selling at their current price levels. 
Via InvestorPlace
Why Ultra Clean Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
Via Benzinga
DexCom (DXCM) Q2 2024 Earnings Call Transcript
DXCM earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.